CME Group (NASDAQ:CME) received a $184.00 price objective from research analysts at Berenberg Bank in a note issued to investors on Thursday, September 20th. The firm presently has a “hold” rating on the financial services provider’s stock. Berenberg Bank’s price target indicates a potential upside of 4.25% from the stock’s previous close.

CME has been the topic of a number of other research reports. Zacks Investment Research upgraded CME Group from a “sell” rating to a “hold” rating in a research report on Tuesday, September 18th. Compass Point began coverage on CME Group in a research report on Monday, July 9th. They set a “neutral” rating and a $170.00 price objective on the stock. BidaskClub downgraded CME Group from a “buy” rating to a “hold” rating in a research report on Tuesday, July 10th. Rosenblatt Securities initiated coverage on CME Group in a research report on Wednesday, September 5th. They issued a “neutral” rating and a $177.00 target price on the stock. Finally, Wells Fargo & Co lifted their target price on CME Group from $170.00 to $175.00 and gave the company a “market perform” rating in a research report on Monday, July 9th. Five research analysts have rated the stock with a hold rating, ten have given a buy rating and one has assigned a strong buy rating to the company. The stock has a consensus rating of “Buy” and an average target price of $178.93.

CME Group stock traded up $0.47 during trading on Thursday, reaching $176.50. 1,734,102 shares of the company were exchanged, compared to its average volume of 1,566,127. CME Group has a 52-week low of $132.33 and a 52-week high of $182.97. The company has a market cap of $57.79 billion, a price-to-earnings ratio of 37.00, a PEG ratio of 3.20 and a beta of 0.64. The company has a debt-to-equity ratio of 0.15, a quick ratio of 1.08 and a current ratio of 1.08.

CME Group (NASDAQ:CME) last announced its quarterly earnings data on Thursday, July 26th. The financial services provider reported $1.74 EPS for the quarter, topping the Zacks’ consensus estimate of $1.72 by $0.02. CME Group had a return on equity of 9.03% and a net margin of 111.45%. The firm had revenue of $1.06 billion for the quarter, compared to the consensus estimate of $1.05 billion. During the same quarter last year, the business posted $1.22 earnings per share. The firm’s revenue was up 14.6% compared to the same quarter last year. On average, analysts predict that CME Group will post 6.64 EPS for the current fiscal year.

In related news, Director Martin J. Gepsman sold 300 shares of the business’s stock in a transaction on Thursday, September 13th. The stock was sold at an average price of $172.30, for a total value of $51,690.00. Following the sale, the director now owns 42,912 shares in the company, valued at approximately $7,393,737.60. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Jeffrey M. Bernacchi sold 4,976 shares of the business’s stock in a transaction on Tuesday, September 4th. The shares were sold at an average price of $176.60, for a total value of $878,761.60. Following the completion of the sale, the director now owns 52,004 shares in the company, valued at approximately $9,183,906.40. The disclosure for this sale can be found here. Insiders sold 26,688 shares of company stock worth $4,523,957 in the last 90 days. Company insiders own 0.43% of the company’s stock.

A number of institutional investors and hedge funds have recently added to or reduced their stakes in CME. Janus Henderson Group PLC grew its stake in CME Group by 13.2% during the 2nd quarter. Janus Henderson Group PLC now owns 6,129,157 shares of the financial services provider’s stock worth $1,004,691,000 after purchasing an additional 716,655 shares in the last quarter. Renaissance Technologies LLC acquired a new position in CME Group during the 2nd quarter worth $96,350,000. Unigestion Holding SA acquired a new position in CME Group during the 2nd quarter worth $96,251,000. Westfield Capital Management Co. LP grew its stake in CME Group by 777.5% during the 1st quarter. Westfield Capital Management Co. LP now owns 610,726 shares of the financial services provider’s stock worth $98,779,000 after purchasing an additional 541,126 shares in the last quarter. Finally, Epoch Investment Partners Inc. grew its stake in CME Group by 51.9% during the 1st quarter. Epoch Investment Partners Inc. now owns 1,545,562 shares of the financial services provider’s stock worth $249,980,000 after purchasing an additional 528,198 shares in the last quarter. 84.03% of the stock is owned by hedge funds and other institutional investors.

CME Group Company Profile

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products, and metals.

See Also: How Important is Technical Analysis of Stocks

Analyst Recommendations for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.